Advisors Asset Management’s NovoCure NVCR Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-887
Closed -$26.4K 1530
2024
Q4
$26.4K Sell
887
-45
-5% -$1.34K ﹤0.01% 1366
2024
Q3
$14.6K Sell
932
-17
-2% -$266 ﹤0.01% 1393
2024
Q2
$16.3K Sell
949
-105
-10% -$1.8K ﹤0.01% 1384
2024
Q1
$16.5K Hold
1,054
﹤0.01% 1373
2023
Q4
$15.7K Sell
1,054
-111
-10% -$1.66K ﹤0.01% 1368
2023
Q3
$18.8K Buy
+1,165
New +$18.8K ﹤0.01% 1364
2023
Q2
Sell
-3,729
Closed -$224K 1449
2023
Q1
$224K Sell
3,729
-1,361
-27% -$81.9K ﹤0.01% 1093
2022
Q4
$373K Sell
5,090
-8,203
-62% -$602K 0.01% 1000
2022
Q3
$1.01M Sell
13,293
-278
-2% -$21.1K 0.02% 719
2022
Q2
$943K Sell
13,571
-280
-2% -$19.5K 0.02% 774
2022
Q1
$1.15M Sell
13,851
-12,665
-48% -$1.05M 0.02% 764
2021
Q4
$1.99M Sell
26,516
-3,576
-12% -$269K 0.03% 609
2021
Q3
$3.5M Sell
30,092
-5,974
-17% -$694K 0.05% 392
2021
Q2
$8M Sell
36,066
-2,434
-6% -$540K 0.12% 166
2021
Q1
$5.09M Sell
38,500
-3,702
-9% -$489K 0.08% 246
2020
Q4
$7.3M Sell
42,202
-831
-2% -$144K 0.12% 157
2020
Q3
$4.79M Sell
43,033
-11,339
-21% -$1.26M 0.09% 212
2020
Q2
$3.22M Sell
54,372
-13,603
-20% -$807K 0.06% 312
2020
Q1
$4.58M Buy
67,975
+1,963
+3% +$132K 0.11% 186
2019
Q4
$5.56M Sell
66,012
-12,758
-16% -$1.08M 0.1% 242
2019
Q3
$5.89M Buy
78,770
+1,634
+2% +$122K 0.11% 227
2019
Q2
$4.88M Buy
77,136
+5,115
+7% +$323K 0.09% 274
2019
Q1
$3.47M Buy
72,021
+13,160
+22% +$634K 0.06% 361
2018
Q4
$1.97M Buy
58,861
+18,383
+45% +$616K 0.04% 507
2018
Q3
$2.12M Buy
40,478
+28,825
+247% +$1.51M 0.03% 586
2018
Q2
$365K Buy
+11,653
New +$365K 0.01% 1125